2014 Annual Meeting | 4HC.001 - Deep Brain Stimulation Management

Date Tuesday 04/29/14

Time 01:00 PM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Half-Day Course

Director(s) Michele Tagliati, MD, FAAN

Topic(s)

Learning Objectives Participants should be able to: describe the rationale for the use of DBS and the patients for whom the treatment is most indicated; have a general understanding of DBS surgery and the possible roles of the neurologist in the O.R.; appreciate the principles of initial DBS stimulator activation and programming; and recognize the issues involved in the short- and long-term management of movement disorder patients treated with DBS.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
01:00 PM - 01:30 PM		DBS for Movement Disorders: Indications, Patient Selection, and Principles of Programming Michele Tagliati, MD, FAAN
01:30 PM - 02:00 PM		Surgical Aspects and Mechanisms of Action of DBS Helen Bronte-Stewart, MD, MSE
02:00 PM - 02:40 PM		Initial Stimulator Programming for Essential Tremor and Parkinson's Disease William J. Marks, Jr., MD, FAAN
02:40 PM - 03:00 PM		Programming Strategies for Dystonia Michele Tagliati, MD, FAAN
03:00 PM - 03:15 PM		Break
03:15 PM - 04:00 PM		Long-term Management and Troubleshooting Michael S. Okun, MD, FAAN
04:00 PM - 04:40 PM		Case Presentations
04:40 PM - 05:00 PM		Questions and Answers

Faculty Disclosures
Michele Tagliati, MD, FAAN	Dr. Tagliati has received publishing royalties from a publication relating to health care.
Helen Bronte-Stewart, MD, MSE	Dr. Bronte-Stewart has nothing to disclose.
William J. Marks, Jr., MD, FAAN	Dr. Marks has received personal compensation for serving as an employee of Verily Life Sciences. Dr. Marks has received stock or an ownership interest from Verily Life Sciences. Dr. Marks has received publishing royalties from a publication relating to health care.
Michael S. Okun, MD, FAAN	Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.